Work

Prognostic Impact of Activating Mutations of the NRAS/KRAS Genes in Patients with Primary and Post-Essential Thrombocythemia (ET)/Polycythemia Vera (PV) Myelofibrosis (MF)

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-120091

Authors: Fabio PS Santos, Bartlomiej Getta, Lucia Masarova, Christopher Famulare, Jessica Schulman, Renato D Puga, Raquel de Melo Alves Paiva, Nelson Hamerschlak, Hagop M. Kantarjian, Ross L. Levine, Paulo Vidal Campregher, Raajit K. Rampal, Srdan Verstovsek

Institutions: Hospital Israelita Albert Einstein, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2920100573

Cites:

Cited by:

Related to: 10